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More than 1500 sequence variations have been reported in the CFTR gene, often
with frequency variations related to geographic or ethnic origin, and which are found
in both CF and related phenotypes – CFTR-related disorders (RD). To completely
characterize the spectrum of CFTR mutations in northern Portugal we screened 26
paediatric CF patients as well as 54 patients with a CFTR-RD (46 with CBAVD
and 8 with disseminated bronchiectasis). The study was carried out by an initial
screening for 33 known CF mutations using a commercial kit, followed by an
extensive screening by DGGE and sequencing analysis. In paediatric patients, the
initial study showed a frequency of 36.5% for the F508del. The frequencies of the
other 9 CF mutations were 3.8% for G542X, N1303K and R334W, while the other
5 were found only once (1.9%). This mutation analysis enabled the detection of
61.5% CF alleles. In the remaining uncharacterized CF alleles (38.5%), whole gene
screening detected 3 further different mutations, increasing the mutation detection
rate to 67.3%. In the 54 CFTR-RD patients, the initial analysis revealed that the
F508del was found in 23.1% of the chromosomes whereas the IVS8(T)5 accounted
for 26.9%. The frequencies of the other 6 CF mutations accounted for a further
17.4%. Extensive analysis detected 20 further mutations, increasing the mutation
detection rate to 89.8%. Our results demonstrated a high allelic heterogeneity for
CF in north of Portugal, as is reported for other southern European populations.
Although an exhaustive screening strategy is being performed in a larger group of
CF patients, the data presented here may be useful for improving genetic testing in
Portugal as well as to genetic counselling.
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CFTR gene mutations vary in their frequency and distribution in different popula-
tions. Some CFTR mutations have a higher frequency in certain populations due to
founder effect in religious, ethnic, geographical isolates.
Western region of Ukraine (10 millions inhabitancies) is located at the strategic
position of central Europe and was populated with Ukrainians, Poles, Jews, Rus-
sians, Germans, Armenians, Czechs, Slovaks, Hungarians, Gypsies. The region’s
historically dominant Ukrainian population (94.8%) diversiﬁes demographically by
the historical origin.
132 CF probands were detected. Eighteen different CFTR gene mutations were
identiﬁed among them. Twenty two different genotypes (two mutations identiﬁed)
are detected among studied group of patients.
43 (33%) CF patients have the same mutations in two alleles. Compound heterozy-
gous F508del with other identiﬁed or unidentiﬁed (13.6%) CFTR mutation were
detected at 45% of CF probands. 13 (9.8%) patients, all Ukrainians by nationality,
have F508del/2184insA genotype. Ten of sixteen patients with 2184insA mutation
(two homozygous among them) are from Lviv region.
N1303K mutation has been detected in combination with different CFTR mutations
(F508del – 7 cases; 3849+10kbC>T, G542X, 2183AA>G, CFTRdele2,3 − each one
case) as well one homozygous at thirteen CF patients, which mostly are from Volyn
and Rivne region.
Slavic deletion CFTRdele2,3(21kb) were detected at ten patientsmethnically
Ukrainians and Russian.
Rare genotypes: 3272−11A>G homozygous, mutation 2721del11 and 1218 T>A
(described for the ﬁrst time) were identiﬁed in patients from Carpathian Mountains
part of Lviv and Ivano-Frankivsk oblast, where geographical isolates are character-
istic.
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Objectives: In Romania, beside the main Romanian population (89%) there are
two other important ethnic groups – Hungarians (6.6%) and Gypsies (3%). The
aim of this study was to estimate the frequency of CFTR mutations in Romanian
population and in the two other ethnic groups.
Methods: Based on clinical ﬁndings and sweat test, we performed genetic testing
for 29 CFTR mutations by ARMS-PCR in 63 patients (52 Romanians, 4 Hungarians
and 7 Gypsies). 105 patients (91 Romanians, 9 Hungarians and 5 Gypsies) were
previously investigated by other methods, PCR-SSCP, RFLP, direct sequencing.
Results: We identiﬁed 22 CFTR mutations (DF508, G542X, N1303K,
621+1G>T, W1282X, I148T, 2183 AA>G, G85E, 1898+1G>A, G576X, R553X,
CFTRdel2,3(21kb), G817V, 3272−26A>G, 457TAT>G, 3849+10kbC>T, R1162X,
3849G>A, S1235R, R117H), four polymorphic variants – 2694T/G, 2694T/C,
IVS8−5T, IVS8−7T and 2 new CFTR mutations – R735K and 1717−2A>G.
Conclusions: The most frequent mutation in Romanian population is DF508 (149
alleles, 52.1%), also for the Hungarian patients (16 alleles, 61.5%) and gypsy
patients (15 alleles, 62.5%). However, the second most frequent mutation in
Romanian population, G542X (11 alleles, 3.84%) was not found in Hungarian
patients and one allele (4.16%) was G542X positive in gypsy patients. Beside
DF508, we identiﬁed three more rare mutations in Hungarian patients (W1282X,
R553X and R1162X) and no other mutations in gypsy patients. It is required to
increase the number of patients with genetic diagnosis from the two ethnic groups
(Hungarians and Gypsies) in order to obtain an improved estimate of their genetic
structure.
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The molecular characterization of cystic ﬁbrosis (CF) in Republic of Macedonia
was initiated in 1989/90. The ﬁrst DF508 screening showed lower frequency of
the mutation than in any of the neighboring countries. With the development of a
specialized CF centre at the University Pediatric Clinic in Skopje from 1997, the
more reliable clinical criteria for diagnosis of CF were introduced. We performed
re-evaluation of the clinical data of all patients diagnosed as having CF and the
cases with non-conclusive clinical ﬁndings and borderline sweat test results were
excluded from the CF registry. The aim of study was to update the molecular basis
of CF in the Republic of Macedonia.
Methods: CFTR mutation analysis were performed in 115 unrelated patients with
conﬁrmed clinical diagnosis of CF. The molecular analysis included: detection of
DF508 as the initial screening; denaturing gradient gel electrophoresis (DGGE) for
mutation detection in exons: 11, 17b, 14b, 14a, 15, 20, 21, 9, 6a, 8, 5 and 18; and
INNO-LiPA CFTR+17Tn kits for identiﬁcation of CFTR mutations.
Results: The molecular defect was determinate in 89.1% (205/230) of the CF
chromosomes. DF508 mutation was present in 73.9% (170/230). 12 other mu-
tations, representing 15.2% of all CF alleles, were also identiﬁed. Only four of
these were more common: G542X (5.6%), N1303K (3.1%), 621+G→T (1.7%)
and CFTRdel21kb (1.3%). The other mutations, including three novel mutations
(711+3A→G, 1811+1G→C and Y569C), were present in isolated cases.
Conclusion: The updated and extended data on the frequency and distribution of
CF mutations detected in a cohort of 115 patients from the Republic of Macedonia
showed high frequency of DF508 mutation. Only four additional mutations were
found with a frequency of more than 1%.
